PhRMA
AUGUST 22, 2022
The Kenneth C. Frazier PhRMA Scholars Program is going strong in 2022—and we are expanding our horizons to a new city. This summer, we are thrilled to announce four new recipients: Arianna Camacho-Mendez and Axel Orellana from Washington, D.C.; and Michelle Tanujaya and Jackie Zhao, our first students from Philadelphia. Congratulations to these amazing scholars!
Pharmacy Times
AUGUST 22, 2022
University of Minnesota Medical School Analysis shows comparison with fluvoxamine and ivermectin in a double-blinded, placebo-controlled, randomized study.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
pharmaphorum
AUGUST 22, 2022
The European Commission has become the first regulator worldwide to approved a therapy from Gilead Sciences for people with multidrug-resistant (MDR) HIV infection that only needs to be taken twice a year, after the FDA rejected it earlier this year. Sunlenca – based on HIV capsid inhibitor lenacapavir – has been approved in the EU for use as an add-on to antiretroviral therapies in patients who are struggling to achieve viral suppression with current drugs.
Pharmacy Times
AUGUST 22, 2022
Overall low awareness of the Omicron variant infection contributed to high transmission rates and rapid spread of SARS-CoV-2 in communities.
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
PharmaVoice
AUGUST 22, 2022
The rare disease veteran and first-time CEO is bringing his expertise to the company as it launches the first FDA-approved treatment for pyruvate kinase (PK) deficiency.
Pharmacy Times
AUGUST 22, 2022
Omnipod 5 is an automated, tubeless insulin dispensing system that allows for continuous infusion and bolus dosing as needed.
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
Pharmacy Times
AUGUST 22, 2022
The announcement marks the first protein-based COVID-19 vaccine authorized in the United States for this patient population.
pharmaphorum
AUGUST 22, 2022
Jack Torrance, investment specialist for Baillie Gifford’s Health Innovation Fund, tells us how the organisation ensures its investments will have the most significant positive impact on all stakeholders within the healthcare ecosystem. . Much of the healthcare system has not changed in line with other sectors or caught up with the advances in digital innovation.
Pharmacy Times
AUGUST 22, 2022
The American Heart Association includes 6 conditions and indicates that men’s and women’s experiences may differ.
PharmaVoice
AUGUST 22, 2022
A look at how the biggest pharma companies in the world and their top-selling drugs fared in the first half of the year.
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
Pharmacy Times
AUGUST 22, 2022
Decision in favor of FDA partially clarifies a somewhat gray area of the law regarding medications.
European Pharmaceutical Review
AUGUST 22, 2022
THE GLOBAL outbreak of the COVID-19 pandemic triggered an urgent need to protect people’s lives and livelihoods and the healthcare community recognised quite early that vaccines were the best solution to this crisis. However, the biopharma industries realised that traditional vaccine development and manufacturing techniques, which take around five to 10 years for initial development to large-scale distribution, 1 were inadequate to meet the growing demand for COVID-19 vaccines.
Outsourcing Pharma
AUGUST 22, 2022
The group has introduced a downloadable guide, interactive quiz, and other tools to inform patients from underrepresented communities about trial participation.
European Pharmaceutical Review
AUGUST 22, 2022
According to a recent survey , 86.9 percent of biopharmaceutical companies outsource at least some of their activities, which has helped make biopharmaceutical contract manufacturing a $14 billion industry. The investigators foresee a highly promising and profitable future for biopharmaceutical contract development and manufacturing organisations (CDMOs) over the next decade.
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
Outsourcing Pharma
AUGUST 22, 2022
A leader from the trial financial management specialist suggests apps used in trials could be adjusted to better suit patients, sites and other stakeholders.
Pharmacy Times
AUGUST 22, 2022
Narcissistic leaders have a negative impact on the culture of their organization as their conduct and management style induces fear.
PharmaVoice
AUGUST 22, 2022
A new, digitally innovative care model empowers patients and expedites their access to treatment.
Pharmacy Times
AUGUST 22, 2022
New drugs, virtual care, and a patient-focused approach are key during this period of transformation.
OctariusRx
AUGUST 22, 2022
The 2022 version of the OctariusRx medication safety quiz is about to be released. Ongoing education and assessments of staff medication management competency are standards of good practice. Medication competency and your consultant pharmacist are two things that should go hand-in-hand. How are you assessing your staff? Use our tool to help enhance patient safety and satisfy the regulatory requirement.
Pharmacy Times
AUGUST 22, 2022
This month's rx product news features Skyrizi (AbbVie), Myfembree (Myovant Sciences, Pfizer), and Dupixent (Regeneron Pharmaceuticals).
pharmaphorum
AUGUST 22, 2022
Akili has started trading publicly today, raising $163 million as a result of its merger with a blank cheque company, saying the cash injection will help fund further development of its video-game based digital therapeutics (DTx). The company made its debut on the Nasdaq on Friday under the AKLI ticker with a starting share price of $9.65, and made swift gains, more than doubling to $20-plus in trading today having spiked as high as $36.
European Pharmaceutical Review
AUGUST 22, 2022
HARDLY A DAY goes by without mention of a newly emerging active pharmaceutical ingredient (API) nitrosamine, eg, nitrosamine propranolol. 1 This has led to a great deal of pre-competitive data sharing. For instance, Lhasa initiated a Nitrites in Excipients database to facilitate risk assessment of drug products, which was recently published. 2,3 The database categorises excipients thus: 1) excipients show varying nitrite contents with pronounced batch-to-batch variance, 2) the nitrite impact is
Pharmaceutical Technology
AUGUST 22, 2022
The World Health Organization (WHO) has made new recommendations for the usage of two monoclonal antibodies to treat the Ebola virus in its first published guideline. mAb114 (Ansuvimab; Ebanga) and REGN-EB3 (Inmazeb) are the two monoclonal antibody treatments recommended by the WHO. The health agency urged the global community to boost access to these lifesaving therapies.
pharmaphorum
AUGUST 22, 2022
The National Cancer Institute (NCI) in the US has said it will make $23 million available to four academic institutions over the next five years to study the role of telehealth for cancer patients. The academic institutions will investigate how telehealth can be deployed ” from prevention to screening and diagnosis to treatment and survivorship,” said the agency, with each becoming a Telehealth Research Centre of Excellence (TRACE) for one aspect of the programme. “During the
Pharmacy Times
AUGUST 22, 2022
Jake Nichols, PharmD, CEO, president, and co-founder of Renovo Health, discusses his experience with drug diversion and addiction.
Outsourcing Pharma
AUGUST 22, 2022
This monthâs news on technology, partnerships, expansions, and more includes items from IQVIA, Almac Group, Signant Health, Lonza, and other key companies.
Pharmacy Times
AUGUST 22, 2022
Zerbaxa is a combination of ceftolozane, a cephalosporin antibacterial, and tazobactam, a beta-lactamase inhibitor.
PharmExec
AUGUST 22, 2022
Tue, Aug 23, 2022 1:00 PM EDT Hear how Werewolf Therapeutics successfully transformed its spend management processes by driving efficiencies; increasing savings; and implementing efficient, compliant systems on a scalable foundation for growth. How do procurement and finance leaders at biopharma companies plan for a future that has unknowns and uncertainty?
Pharmacy Times
AUGUST 22, 2022
AON receives ranking no. 107 among America’s fastest-growing private companies and no. eight among health services.
Pharmaceutical Technology
AUGUST 22, 2022
Porton Advanced Solutions has raised $80m in a Series B funding round to expand its end-to-end gene and cell therapy (GCT) contract development and manufacturing organisation (CDMO) platforms. Merchant Health, a healthcare private equity (PE) fund of China Merchants Groups, led the financing round together with its sister fund China Merchants Capital and China Merchants Securities Investments.
pharmaphorum
AUGUST 22, 2022
As the healthcare industry emerges at last from the COVID-19 pandemic into a new, digitally supercharged world, stakeholders across the industry must move fast to embrace digital transformation. At the 2022 Frontiers Health conference in Milan, thought leaders and industry experts from across the life sciences will come together to discuss this transformation and the future of digital health.
Pharmaceutical Technology
AUGUST 22, 2022
When it comes to pharmaceutical, nutritional or cosmeceutical dosing, some of the most crucial parameters are safety, product effectiveness and patient adherence. The right formulation can have a huge impact on whether the customer continues taking their capsules, as well as whether the ingredients act as intended. Today, innovations in the capsule formulation space are creating new possibilities for how capsules look, feel and act, with huge benefits for customers.
pharmaphorum
AUGUST 22, 2022
The EMA’s Emergency Task Force (ETF) has recommended that EU member states can use a different regimen for Bavarian Nordic’s monkeypox vaccine Imvanex/Jynneos that uses a smaller dose, to eke out limited supplies of the shot. The recommendation comes after a review of a clinical trial which found that delivering a smaller dose intradermally – just below the top layer of the skin – is as effective as giving the standard dose subcutaneously as recommended on the monkeypox vaccine’
Pharmacy Times
AUGUST 22, 2022
Aobbiy is a lung expansion and mucus relief device that aids in mucus removal to help clear the airway.
Expert insights. Personalized for you.
130 
Let's personalize your content